Homepage Variant Selector
Pick a style to preview the full homepage system.
Strategic
Financial
Leadership
Two decades of Fortune 500 experience distilled into fractional CFO services for biopharma companies ready to scale with precision.
Strategic Finance
For Ambitious Companies
From startup to scale-up, I deliver the financial infrastructure, forecasting, and strategic insight that turns complexity into competitive advantage.
Fractional CFO
Executive-level financial leadership without the full-time overhead. Strategic guidance for growth-stage companies.
- Board presentations
- Strategic planning
- Executive coaching
FP&A & Forecasting
Build robust forecasting models and reporting frameworks that give leadership clarity and confidence.
- Budgeting & planning
- Power BI dashboards
- Variance analysis
Capital Strategy
Optimize your capital structure and allocation to fuel growth while maintaining financial stability.
- Liquidity management
- Treasury strategy
M&A Due Diligence
Comprehensive financial diligence that protects value and surfaces critical risks before deals close.
- Target evaluation
- Integration planning
Board-Ready Reporting
Clear, compelling financial narratives that help boards make informed strategic decisions.
- SEC filing support
- Audit materials
Performance Transformation
Identify and execute on operational improvements that drive sustainable profitability.
- Cost optimization
- Process automation
25+ Years of Excellence
Global biopharma to growth-stage ventures
Global Finance Leadership
Engineering foundation. Financial mastery. 25+ years driving transformation.
Yasser Hazzaa
CFO Consultant & Board Advisor
Education
MBA, Maastricht School
Credentials
CPA (California)
Location
Oak Park, CA
Languages
English, Arabic (Fluent)
Career Highlights
$17B
Business Led at BMS
600%
Market Cap Growth
30+
Markets Served
25+
Years Experience
"My engineering mindset brings systems-thinking to financial strategy."
Recent Timeline
2025–Present
Board Member
TesoRx Pharma & Lipac Oncology
2017–2025
VP Finance
MannKind Corporation
2011–2016
Director, Corporate FP&A
Bristol-Myers Squibb
2009–2010
Associate Director Finance – Europe
Bristol-Myers Squibb
Signature Achievement
Deep-dive into transformative financial leadership that defined a seven-year growth journey.
~600% Market Cap Growth
Partnered with CEO and CFO to architect financial discipline supporting transformative market cap growth over seven years. Led FP&A, capital strategy, and board reporting during critical growth phases.
20%+
Reporting Improvement
Cross-Functional
Global Team
Exceptional financial leadership that transformed our strategic planning capabilities.
Leadership Team
MannKind Corporation
150+
FP&A Community
Bristol-Myers Squibb
FP&A COE Lead, 2015–2016
Built global FP&A excellence community.
$17B
P&L Managed
Bristol-Myers Squibb
Director Corporate FP&A, 2011–2015
Led Long-Term Financial Planning for major franchises.
Let's build
something
exceptional
Strategic CFO support for biopharma companies ready to scale. Board-ready insights from a Fortune 500 veteran. Let's discuss how I can accelerate your financial strategy.
yasser.hazzaa@gmail.com
Phone
+1 (609) 865-8068
linkedin.com/in/yasserhazzaa
Available for Q2 engagements
Response time: Within 24 hours
Book a Consultation
Fill out the form below to get started